GT Biopharma GTBP
NASDAQ GTBP
$3.72 -0.12 (-3.12%)
At close: Nov 13, 2026 · 4:00 PM EST

GT Biopharma (GTBP) Change in Receivables (2009 - 2014)

Updated

GT Biopharma (GTBP) reported Change in Receivables of -$25,000 for Q2 2014.

Analysis

GT Biopharma (GTBP) Change in Receivables (2009 - 2014) Analysis & Trends

For FY2013, GT Biopharma posted Change in Receivables of $40,000.

  • The Q2 2014 figure ranks as the lowest quarterly Change in Receivables since Q3 2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -188.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -312.00 Mn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 108.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -52.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 GT Biopharma 6.65 Mn -16.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2014 -25,000.00
Mar 31, 2014 -10,000.00
Sep 30, 2009 -3.00 Mn
Jun 30, 2009 -6.00 Mn
Mar 31, 2009 -4.00 Mn
API Access

GT Biopharma Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=GTBP&period=max&api_key=YOUR_API_KEY